Copyright
©The Author(s) 2024.
World J Clin Oncol. Apr 24, 2024; 15(4): 531-539
Published online Apr 24, 2024. doi: 10.5306/wjco.v15.i4.531
Published online Apr 24, 2024. doi: 10.5306/wjco.v15.i4.531
Figure 1 Seven types of variable splicing in vivo.
(1) ES: Exon skip; (2) RI: Retained intron; (3) AD: Alternate Donor site; (4) AA: Alternate acceptor site; (5) AP: Alternate promoter; (6) AT: Alternate terminator; (7) ME: Mutually exclusive exons.
- Citation: Geng DY, Chen QS, Chen WX, Zhou LS, Han XS, Xie QH, Guo GH, Chen XF, Chen JS, Zhong XP. Molecular targets and mechanisms of different aberrant alternative splicing in metastatic liver cancer. World J Clin Oncol 2024; 15(4): 531-539
- URL: https://www.wjgnet.com/2218-4333/full/v15/i4/531.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i4.531